Jonathan J Taliercio
Overview
Explore the profile of Jonathan J Taliercio including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
330
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Peschard V, Scherzer R, Estrella M, Sarnak M, Ascher S, Lash J, et al.
Clin J Am Soc Nephrol
. 2025 Mar;
PMID: 40085155
Background: Individual kidney tubule biomarkers are associated with risks for chronic kidney disease (CKD) progression and mortality in persons with diabetes. Integrating multiple kidney biomarkers using a latent variable method...
2.
Sarcopenia may increase cisplatin toxicity in bladder cancer patients with borderline renal function
Haile E, Lone Z, Shin D, Nowacki A, Soputro N, Harris K, et al.
BJU Int
. 2024 Dec;
PMID: 39654302
Objectives: To assess whether the effect of sarcopenia on neoadjuvant chemotherapy (NAC) toxicity is modified by borderline renal function (estimated glomerular filtration rate [eGFR] 40-65 mL/min) and whether sarcopenia and...
3.
Nakhoul G, Taliercio J, Bassil E, Arrigain S, Schold J, Wardrop R, et al.
Kidney Int Rep
. 2024 Sep;
9(9):2619-2626.
PMID: 39291202
Introduction: Recent technological advancements allowed the development of engaging technological tools. Using ASN funding from the ASN, we developed a 3D Virtual Reality (VR) physiology course entitled DiAL-Neph (Diuretic Action...
4.
Bassil E, Nakhoul G, Taliercio J, Mehdi A
Cleve Clin J Med
. 2024 Jul;
91(7):397-399.
PMID: 38950982
No abstract available.
5.
Aminian A, Gasoyan H, Zajichek A, Alavi M, Casacchia N, Wilson R, et al.
Ann Surg
. 2024 Jun;
280(3):414-423.
PMID: 38860374
Objective: To examine the renoprotective effects of metabolic surgery in patients with established chronic kidney disease (CKD). Background: The impact of metabolic surgery compared with glucagon-like peptide-1 receptor agonists (GLP-1RA)...
6.
Bassil E, Nakhoul G, Taliercio J, Mehdi A
Cleve Clin J Med
. 2024 Apr;
91(4):221-227.
PMID: 38561209
No abstract available.
7.
Kanaan C, Layoun H, Kondoleon N, Fadel R, Mirzai S, Schold J, et al.
Am Heart J Plus
. 2024 Mar;
25:100234.
PMID: 38510498
Study Objective: Data is scarce regarding which dialysis modality portends more severe cardiac valvular calcification (CVC). Our aim was to compare the degree of CVC in hemodialysis (HD) and peritoneal...
8.
Salupo N, Norris M, Taliercio J
J Osteopath Med
. 2024 Jan;
124(5):241-242.
PMID: 38281063
No abstract available.
9.
Ishigami J, Jaar B, Charleston J, Lash J, Brown J, Chen J, et al.
Am J Kidney Dis
. 2023 Sep;
83(2):196-207.e1.
PMID: 37717847
Rationale & Objective: Vaccination for influenza is strongly recommended for people with chronic kidney disease (CKD) due to their immunocompromised state. Identifying risk factors for not receiving an influenza vaccine...
10.
Taliercio J, Mehdi A
Cleve Clin J Med
. 2023 May;
90(6 suppl 1):e5-e8.
PMID: 37225260
Immunoglobulin A nephropathy (IgAN) is the most common glomerulonephritis in the world. The etiology is unknown but a dysregulated T-cell immune response to viral, bacterial, and food antigens activating mucosal...